Elshafae, S.M.; Kohart, N.A.; Breitbach, J.T.; Hildreth, B.E., III; Rosol, T.J.
The Effect of a Histone Deacetylase Inhibitor (AR-42) and Zoledronic Acid on Adult T-Cell Leukemia/Lymphoma Osteolytic Bone Tumors. Cancers 2021, 13, 5066.
https://doi.org/10.3390/cancers13205066
AMA Style
Elshafae SM, Kohart NA, Breitbach JT, Hildreth BE III, Rosol TJ.
The Effect of a Histone Deacetylase Inhibitor (AR-42) and Zoledronic Acid on Adult T-Cell Leukemia/Lymphoma Osteolytic Bone Tumors. Cancers. 2021; 13(20):5066.
https://doi.org/10.3390/cancers13205066
Chicago/Turabian Style
Elshafae, Said M., Nicole A. Kohart, Justin T. Breitbach, Blake E. Hildreth, III, and Thomas J. Rosol.
2021. "The Effect of a Histone Deacetylase Inhibitor (AR-42) and Zoledronic Acid on Adult T-Cell Leukemia/Lymphoma Osteolytic Bone Tumors" Cancers 13, no. 20: 5066.
https://doi.org/10.3390/cancers13205066
APA Style
Elshafae, S. M., Kohart, N. A., Breitbach, J. T., Hildreth, B. E., III, & Rosol, T. J.
(2021). The Effect of a Histone Deacetylase Inhibitor (AR-42) and Zoledronic Acid on Adult T-Cell Leukemia/Lymphoma Osteolytic Bone Tumors. Cancers, 13(20), 5066.
https://doi.org/10.3390/cancers13205066